The case for case-by-case regulation of PGD: a response to Dr David King

The Genetic Interest Group (GIG) welcomed the UK's Human Fertilisation and Embryology Authority (HFEA)’s review of the case-by-case approach to the licensing of preimplantation genetic diagnosis (PGD) for late-onset conditions and for tissue typing of embryos to produce a 'saviour sibling'. I attended the HFEA's consultation event at which Dr David King spoke on 1 December last year and heard his presentation. Then, as in his BioNews comment

Patients want 'hybrid' embryo research to go ahead

The UK's Human Fertilisation and Embryology Authority (HFEA) has announced a public consultation on the creation of human-animal hybrid embryos. Scientists want to use such embryos to create genetically human embryonic stem cells(ES cells). This method would overcome difficulties associated with the collection of human eggs from donors, and would...[Read More]